New York Bill Would Reject Some FDA Restrictions on Dying Patients
ALBANY, N.Y. (Jan. 18, 2016) – A bill introduced in the New York Senate sets the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Introduced by Sen. Kemp Hannon (R-Nassau County), Senate Bill 2044 (S2044) would give terminally ill patients access…